TEDCO

HeMemics Biotechnologies Inc. is a privately held biosensor company based in Gaithersburg, Maryland, specializing in the research and development of advanced diagnostic test platforms for detecting bacterial and viral pathogens. Established in 2009, the company is finalizing a novel testing platform that aims to deliver near PCR-level accuracy at the cost of lateral-flow tests. This innovative system features a rugged, low-cost handheld reader and a disposable biosensor capable of simultaneously detecting up to 32 pathogens through patented desiccation technology. Results can be obtained in under five minutes, making it a rapid point-of-care tool. The platform is designed for versatile applications, including public health, defense, and national security, and can be integrated with cloud-based data analytics to monitor emerging health threats in real-time.

Pathotrak specializes in rapid food safety testing. Its patented technology reduces detection time of pathogens like Salmonella and E. coli from days to hours, meeting FDA and USDA regulations. This innovation helps minimize holding costs, enables swift recalls, and enhances overall food safety.

Novel Microdevices, LLC is a medical device company that specializes in the development of handheld devices for molecular diagnostics. Founded in 2014 and headquartered in Annapolis, Maryland, the company has created the NOVEL DX device, which employs microfluidics technology to analyze raw biological samples at the point of care. This device delivers results in approximately 30 minutes, allowing healthcare professionals to achieve lab-quality diagnostics without the need for a traditional laboratory setting. Novel Microdevices caters to various sectors, including clinical diagnostics, biodefense, food safety, forensics, drug discovery, animal care, and agriculture, thus addressing a wide range of applications in health and safety.

Impruvon Health develops a medical technology platform for automated medication management designed for individuals who have difficulty maintaining regimens at home or in long-term care, and for the people who support them. The platform is tailored for groups such as those with intellectual or developmental disabilities, individuals recovering from addiction, and veterans. It automates storage, administration, and record keeping to reduce errors and enhance independence and security for patients. It uses smart alerts, reminders, and live alerts of unauthorized access to help healthcare providers keep medications from being misused or diverted. It addresses the impact of medication errors on patients and families and aims to stop errors, thefts, and overdoses while improving compliance and safety for patients and caregivers.

Founded in 2015, Nanobiofab specializes in manufacturing smart, nanotech-based wearable healthcare devices for humans and pets. Its flagship product, iNose, detects and monitors skin vapor-print wirelessly via mobile phone, tracking fat burning rate, exercise effectiveness, and metabolic rate over time.

NextStep Robotics Inc. develops a portable ankle rehabilitation device that treats foot drop by providing real‑time, graded assistance during gait training. The system combines advanced robotics with adaptive software that tailors assistance to each patient’s needs and, as more data accumulate, transitions to an AI‑driven platform that optimizes training protocols. Designed for use in outpatient clinics, the device can be operated by lower‑skilled staff, freeing therapists to focus on other modalities. It is classified as a Class 1 exercise device, allowing immediate market entry without FDA approval. The company generates revenue through direct sales or leasing of the hardware, subscription fees for the software, and service contracts, while enabling clinics to bill for gait training under existing CPT codes.

Founded in 2017, JuneBrain develops wearable, non-invasive imaging devices for multiple sclerosis (MS) patients to monitor their disease activity at home. This enables early detection of MS attacks and improves treatment efficacy monitoring.

Sonogen Medical develops a medical device platform that uses shear wave acoustics and ultrasonic stimulation to accelerate bone fracture repair and monitor healing progress. The system delivers low-intensity pulsed ultrasound in a multi-modal approach, with an integrated capability to track fracture healing over time. It targets fractures that fail to heal properly, addressing a multi-billion dollar annual opportunity in fracture care. The technology aims to shorten treatment times, improve patient outcomes, and provide clinicians with actionable feedback on bone repair, including nonunions and delayed unions.

Sisu Global Health is a medical device manufacturer focused on developing innovative solutions for blood management in emergency situations. The company produces a handheld mechanical device designed to salvage, filter, and recycle blood from patients experiencing internal bleeding. This device is particularly useful during surgical procedures, as it allows healthcare professionals to collect blood lost from internal hemorrhages and use it to augment or replace donor blood. This technology is especially critical in cases of blunt trauma and complications during early pregnancy, thereby enhancing patient care and reducing reliance on donor blood in urgent medical scenarios.

Linshom develops continuous respiratory monitoring solutions for bedside and home use, providing an operating-room quality respiratory profile including tidal volume through wearable, FDA-cleared sensors. The system enables continuous predictive monitoring of respiration, delivering early warnings of respiratory decline to help reduce rapid-response activations, rescue events, and ICU transfers. By capturing respiration data and relative tidal volume at the point of care, Linshom addresses an unmet clinical need with actionable insights for clinicians.

Founded in 2015, Nanobiofab specializes in manufacturing smart, nanotech-based wearable healthcare devices for humans and pets. Its flagship product, iNose, detects and monitors skin vapor-print wirelessly via mobile phone, tracking fat burning rate, exercise effectiveness, and metabolic rate over time.

HeMemics Biotechnologies Inc. is a privately held biosensor company based in Gaithersburg, Maryland, specializing in the research and development of advanced diagnostic test platforms for detecting bacterial and viral pathogens. Established in 2009, the company is finalizing a novel testing platform that aims to deliver near PCR-level accuracy at the cost of lateral-flow tests. This innovative system features a rugged, low-cost handheld reader and a disposable biosensor capable of simultaneously detecting up to 32 pathogens through patented desiccation technology. Results can be obtained in under five minutes, making it a rapid point-of-care tool. The platform is designed for versatile applications, including public health, defense, and national security, and can be integrated with cloud-based data analytics to monitor emerging health threats in real-time.

SeeTrue Technology enhances injection procedures by reducing cell adherence, tissue damage, and improving needle visibility. Their innovative injection needle transforms the biomedical industry.

Kubanda Cryotherapy specializes in minimally invasive, non-surgical treatments for lumps, bumps, and cancers in pets. The company has developed an innovative cryoablation technology that utilizes a custom-designed cryosystem, featuring a cryoprobe and a gas-control module to precisely modulate temperature. This system employs controlled freezing cycles that have been demonstrated to effectively shrink and eliminate tumors. By providing a point-of-care solution, Kubanda Cryotherapy enables veterinarians and pet owners to access high-quality care for their animals without the need for surgical procedures.

Djit Medtech develops a finger joint implant device aimed at relieving pain and preserving movement in patients with advanced hand arthritis.

SeeTrue Technology enhances injection procedures by reducing cell adherence, tissue damage, and improving needle visibility. Their innovative injection needle transforms the biomedical industry.

Linshom develops continuous respiratory monitoring solutions for bedside and home use, providing an operating-room quality respiratory profile including tidal volume through wearable, FDA-cleared sensors. The system enables continuous predictive monitoring of respiration, delivering early warnings of respiratory decline to help reduce rapid-response activations, rescue events, and ICU transfers. By capturing respiration data and relative tidal volume at the point of care, Linshom addresses an unmet clinical need with actionable insights for clinicians.

Lasarrus is a medical device company founded in 2013 and headquartered in Baltimore, Maryland. The company specializes in developing wearable devices aimed at enhancing the physical therapy experience for patients, particularly those with chronic obstructive pulmonary disease. Lasarrus's innovative device facilitates remote monitoring and telemedicine by capturing physiological and range-of-motion data from various points on the body. This technology provides patients with an affordable, comfortable, and non-invasive means to track their health routines and accelerate their recovery process.

Founded in 2015, Nanobiofab specializes in manufacturing smart, nanotech-based wearable healthcare devices for humans and pets. Its flagship product, iNose, detects and monitors skin vapor-print wirelessly via mobile phone, tracking fat burning rate, exercise effectiveness, and metabolic rate over time.

Opal HTM enhances hospital safety and efficiency by employing innovative technologies to revolutionize medical equipment management and maintenance.

BLOCKsyncop is a company focused on developing innovative clinical monitoring devices aimed at enhancing anesthesiology practices. Its primary product is a non-invasive, real-time tool designed to objectively measure and quantify the effectiveness of neural blocks for pain management. This technology assists anesthesiologists in reducing the occurrence of failed neural blocks, minimizing anesthetic toxicity, and optimizing the analgesic requirements for patients. By providing precise data, BLOCKsyncop aims to improve patient outcomes in pain management and support healthcare professionals in delivering safer and more effective anesthesia care.

ExPulsus creates a blood pressure monitoring device for critical care patients that employs a revolutionary pressure sensing technique that is non-invasive, has a minimal risk of complications, and is a low-cost method of monitoring sick ICU patients.

Tomorrow's Bio Today is a developer of innovative medical devices designed for veterinary use, specifically targeting large animals such as cows and horses. The company specializes in ingestible tablet cameras that capture images of the gastrointestinal tracts of these animals. This technology transmits the collected images to a mobile application, offering a safer, more cost-effective, and comprehensive alternative to traditional endoscopic procedures. By enhancing the methods available for internal examinations, Tomorrow's Bio Today aims to assist healthcare professionals in diagnosing conditions like early-stage colorectal cancer in large animals, ultimately benefiting veterinarians and farmers through improved diagnostic capabilities.

Intraderm is developing a medical device to address Wrong Site Surgery, a difficulty in the treatment of skin cancer.

Founded in 2015, Nanobiofab specializes in manufacturing smart, nanotech-based wearable healthcare devices for humans and pets. Its flagship product, iNose, detects and monitors skin vapor-print wirelessly via mobile phone, tracking fat burning rate, exercise effectiveness, and metabolic rate over time.

CarrTech is a medical device company that specializes in improving the safety and efficiency of administering medications packaged in glass ampules. It has patented an integrated, all-in-one package with a single needle for filtering these medications, pioneering a safer, more efficient, and cost-effective method.

CarrTech is a medical device company that specializes in improving the safety and efficiency of administering medications packaged in glass ampules. It has patented an integrated, all-in-one package with a single needle for filtering these medications, pioneering a safer, more efficient, and cost-effective method.

Founded in 2017, JuneBrain develops wearable, non-invasive imaging devices for multiple sclerosis (MS) patients to monitor their disease activity at home. This enables early detection of MS attacks and improves treatment efficacy monitoring.

Vixiar Medical, established in 2013 and headquartered in Annapolis, Maryland, specializes in developing non-invasive, cost-effective devices and systems for monitoring cardiopulmonary diseases. Its flagship product, Indicor, is a handheld point-of-care device and digital platform designed to monitor and manage worsening heart failure. Vixiar's devices aim to enhance clinical workflow and deliver economic value to the healthcare system by enabling monitoring in various settings, including homes, offices, nursing homes, and hospitals.

ReGelTec develops injectable hydrogel technology for treating chronic lower back pain caused by degenerative disc disease. Its proprietary gel transitions from liquid to solid within the intervertebral disc, mimicking natural disc biomechanics and maintaining spinal motion.

CoapTech is an early-stage medical device company based in Baltimore, Maryland, founded in 2016 by Dr. Tropello. The company specializes in researching and manufacturing ultrasound-based solutions for feeding tube placement. Its flagship product, the Point-of-care Ultrasound Magnet Aligned (PUMA-G) System, utilizes a patent-pending technology called Coaptive Ultrasound to enhance safety and reduce healthcare costs. This system employs strong rare-earth magnets for device guidance and real-time, low-cost ultrasound for visual feedback, enabling non-surgical providers to perform procedures such as Percutaneous Ultrasound Gastrostomy (PUG). By eliminating risks associated with traditional methods like organ damage, infections, or cancer from fluoroscopy, CoapTech aims to improve medical care delivery globally.

Founded in 2015, Nanobiofab specializes in manufacturing smart, nanotech-based wearable healthcare devices for humans and pets. Its flagship product, iNose, detects and monitors skin vapor-print wirelessly via mobile phone, tracking fat burning rate, exercise effectiveness, and metabolic rate over time.

ARMR Systems develops wearable hemorrhage control systems that increase survivability of traumatic battlefield injuries when advanced medical support is unavailable. The company’s products combine an ergonomically fitted harness with a tourniquet‑style direct‑pressure device to rapidly compress damaged arteries in critical torso‑junctional areas, limiting blood loss. Founded in 2014 and headquartered in Baltimore, Maryland, ARMR collaborates with military and medical institutions to refine its technology. Its multidisciplinary team applies diverse perspectives to evaluate and improve trauma‑care solutions, providing warfighters, combat medics, and other field personnel with reliable, life‑saving capabilities.

NextStep Robotics Inc. develops a portable ankle rehabilitation device that treats foot drop by providing real‑time, graded assistance during gait training. The system combines advanced robotics with adaptive software that tailors assistance to each patient’s needs and, as more data accumulate, transitions to an AI‑driven platform that optimizes training protocols. Designed for use in outpatient clinics, the device can be operated by lower‑skilled staff, freeing therapists to focus on other modalities. It is classified as a Class 1 exercise device, allowing immediate market entry without FDA approval. The company generates revenue through direct sales or leasing of the hardware, subscription fees for the software, and service contracts, while enabling clinics to bill for gait training under existing CPT codes.

xMD Diagnostics, based in Annapolis, Maryland, specializes in the biotechnology sector, focusing on molecular diagnostics tools that enhance research and clinical laboratory practices. Formerly known as Bay Resources Development Group, the company employs advanced high-throughput microdissection technology to aid in cancer diagnosis. Its innovative tools enable the isolation and enrichment of specific cells from biopsy and other specimen samples, facilitating downstream applications such as polymerase chain reaction (PCR), genomic and proteomic analyses, next-generation sequencing (NGS), and various molecular testing methods. This technology supports pathologists, oncologists, and other medical professionals in diagnosing, monitoring, and treating patients with cancer and serious genetic diseases.

Linshom develops continuous respiratory monitoring solutions for bedside and home use, providing an operating-room quality respiratory profile including tidal volume through wearable, FDA-cleared sensors. The system enables continuous predictive monitoring of respiration, delivering early warnings of respiratory decline to help reduce rapid-response activations, rescue events, and ICU transfers. By capturing respiration data and relative tidal volume at the point of care, Linshom addresses an unmet clinical need with actionable insights for clinicians.

Vixiar Medical, established in 2013 and headquartered in Annapolis, Maryland, specializes in developing non-invasive, cost-effective devices and systems for monitoring cardiopulmonary diseases. Its flagship product, Indicor, is a handheld point-of-care device and digital platform designed to monitor and manage worsening heart failure. Vixiar's devices aim to enhance clinical workflow and deliver economic value to the healthcare system by enabling monitoring in various settings, including homes, offices, nursing homes, and hospitals.

Sonavex develops imaging technologies for vascular and surgical care, employing ultrasound to detect postoperative blood clots at the point of care and to measure intravascular flow metrics for timely decision making. It also develops bioresorbable, echogenic devices to mark at-risk vessels and to collect data on arteriovenous fistula flow, diameter, and depth at dialysis clinics to assess maturation and anticipate future complications. Based in Baltimore, Maryland, Sonavex focuses on delivering data-driven visualization of vessel health to improve surgical and dialysis patient outcomes.

Cordex Systems designs and manufactures a cardiovascular diagnostic device. Its product includes the Cordex EnDys System is a diagnostic tool that provides both early detection and ongoing monitoring of cardiovascular disease by measuring endothelial dysfunction.

Untethered Labs, Inc. is a technology company based in College Park, Maryland, founded in 2015. It specializes in developing wireless security solutions for the enterprise security and access control markets. The company's flagship product, GateKeeper, is a Bluetooth-based keyfob that automatically locks and unlocks a user's computer based on proximity. This innovation addresses critical needs for hardware-based authentication and privacy, making it particularly valuable for industries such as healthcare, which must comply with HIPAA regulations, as well as for large organizations that prioritize data integrity and security. By providing modern access control solutions, Untethered Labs aims to enhance security protocols for both small and large enterprises.

Otomagnetics develops and manufactures a magnetic injection delivery system designed to non-invasively administer therapies to various compartments of the inner and middle ear, as well as the eye and skin. Incorporated in 2012, the company is headquartered in Rockville, Maryland.

Fusiform, Inc. specializes in developing software solutions for the design and fabrication of orthotic devices. Its platform allows users to scan, generate, and annotate 3D models, facilitating the scheduling of patient appointments for clinicians and enabling vendors to manage orders and collaborate with customers. The software supports a wide range of products, including orthoses and prostheses, effectively streamlining the orthopedic device supply chain from patient assessment to manufacturing. Founded in 2015, Fusiform, Inc. is headquartered in Oakland, Maryland.

Noble Life Sciences is a contract research organization based in Gaithersburg, Maryland, founded in 2010. It specializes in providing preclinical drug development services to the biotech, pharmaceutical industries, and academia. The company offers a range of services including disease and animal models, drug pharmacology, exploratory toxicology, oncology drug evaluation, and custom polyclonal antibodies. Additionally, Noble Life Sciences provides vivarium services for small animals, regulatory oversight, veterinary care, breeding, husbandry, technical support, and protocol review. It also supports the development of medical devices through testing services for orthopedics, cardiovascular, trauma, and wound healing applications. The company's state-of-the-art laboratory facility and experienced staff ensure high-quality preclinical contract services, aiding in the efficient transition from concept to clinic.

Rehabtics is a scalable online game-based physical rehabilitation system for institutional and residential use. The system enables its patients to conduct physical therapy by playing motion-controlled video games at the convenience of their homes with automatic feedback and guidance. Rehabtics was launched in 2012 by Xiaoxu Kang and is operated from Baltimore, Maryland.